QingSong Health Corporation (HKEX: 02661) has reported no movements in authorised, issued or treasury shares for the month ended 30 April 2026, according to its monthly return filed on 6 May 2026.

The company’s authorised capital remains at 500.00 million ordinary shares with a par value of USD 0.0001, equivalent to USD 50,000. Issued shares stand unchanged at 206.37 million, and the firm continues to hold no treasury shares.

Public-float compliance was reaffirmed, with management confirming that the minimum 25% free-float requirement under HKEX Main Board Rules has been met.

Under the Pre-IPO Share Option Scheme adopted in 2015 and amended in 2017, 28.09 million share options were outstanding at month-end, identical to the prior month. No options were granted, exercised, cancelled or lapsed during April. The outstanding options equate to approximately 13.61% of the current issued share capital, with the final tranche expiring on 2 December 2035.

The filing states there were no warrants, convertible securities or other agreements that could affect the share capital, and the company raised no funds during the period.

Overall, QingSong Health’s capital structure and share count remained unchanged throughout April 2026, with the only potential dilution stemming from its existing option pool.